Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22 Reuters Vodafone To Sell Hungarian Business For $1.8B: Report Vodafone Group Plc (NASDAQ: VOD ) forged an agreement with Hungarian 4iG and state-run Corvinus Zrt to divest its Hungarian business for 715 billion forints ($1.8 billion) in cash, Reuters reports. The deal excluding Vodafone’s shared services business VOIS will likely create Hungary’s second largest telecoms operator. “The Hungarian Government has a clear strategy to build a Hungarian-owned national champion in the (Information and Communications Technology) sector,” Vodafone CEO Nick Read said. FDA Says Study Needed To Assess Another Round Of Pfizer’s COVID-19 Pill As Infection Rebounds The FDA has asked Pfizer Inc (NYSE: PFE ) to test an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment. According to the Reuters report, the company must produce the initial results of a randomized controlled trial of a second course of the antiviral by September 30 next year. The National Institutes of Health studied 13,644 COVID-19 patients treated with Paxlovid or Merck Co Inc’s (NYSE: MRK ) molnupiravir within five days of their COVID-19 infection.